Stereotactic radiotherapy after incomplete transarterial (chemo-) embolization (taetace) versus exclusive tae or tace for treatment of inoperable hcc: a phase iii trial (nct02323360)

HIGHLIGHTS

• who: Tiziana Comito and colleagues from the Rozzano, Milan, Italy Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy have published the research: Stereotactic Radiotherapy after Incomplete Transarterial (Chemo-) Embolization (TAETACE) versus Exclusive TAE or TACE for Treatment of Inoperable HCC: A Phase III Trial (NCT02323360), in the Journal: (JOURNAL) of 22/09/2022
• what: The aim of this study is to assess the role of SBRT in the multimodality management of unresectable HCC following an insufficient response to the first course of TAE/TACE as compared to TAE/TACE continuation in a phase . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.